Gregorio Fariña
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gregorio Fariña has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Gabriela Berg
Laboratorio de Lípidos y Aterosclerosis, Departamento de Bioquímica Clínica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina
5 shared publications - Johnayro Gutiérrez-Restrepo
Universidad de Antioquía, Medellín, Colombia
3 shared publications - Juan Patricio Nogueira
Endocrinology, Nutrition and Metabolism Research Center, Faculty of Health Sciences, Universidad Nacional de Formosa, Formosa, Argentina
3 shared publications - Pablo Castaño
Clínica SOMER, Rionegro, Antioquia, Colombia
2 shared publications - Adriana Carolina Forero Torres
Pediatric Endocrinology Section, Department of Pediatrics and Childcare, Faculty of Medicine , University of Antioquia , Medellín , Colombia
1 shared publication Alejandro Castellanos Pinedo
San Jerónimo Hospital, Montería, Colombia
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 70 (5) , 1-6
Clinical and functional evidence supporting pathogenicity of a novel APOA5 variant in familial chylomicronemia syndrome
Objective: This study aimed to evaluate the clinical and functional impact of a novel apolipoprotein A5 (ApoA5) variant by assessing lipoprotein lipase (LPL) activity. Subjects and methods: Demographic and clinical data, including blood lipid levels and body mass index, were retrospectively collected from an endocrinology clinic registry. Ten individuals with familial chylomicronemia syndrome (FCS) carrying a novel APOA5 variant were included. Whole-exome sequencing was performed using the latest generation DNB-SEQ400 platform. LPL activity was measured in post-heparin plasma using a radiometric assay. Statistical analysis: Categorical variables were summarized as frequencies and percentages, and continuous variables as mean ± standard deviation or median (range), as appropriate. Group comparisons were performed using the Mann-Whitney U test or chi-square test. Analyses were conducted using the Statistical Package for the Social Sciences software (v. 25.0). A p-value < 0.05 was considered statistically significant. Results: We report ten cases of FCS with a homozygous missense variant of uncertain significance in APOA5: c.694T>C; p.(Ser232Pro), located in exon 3. In six patients assessed for LPL activity, levels remained consistently below 20% compared to normotriglyceridemic controls. The addition of exogenous serum containing APOA5 restored LPL activity to above 20% in all cases, indicating functional rescue. Conclusion: Measurement of LPL activity demonstrated the functional impact of the APOA5 c.694T>C; p.(Ser232Pro) variant. These findings support reclassification of the variant as likely pathogenic and enable differentiation from multifactorial chylomicronemia syndrome.
- 1 January 2026
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 70 (5) , 1-6
Open AccessClinical and functional evidence supporting pathogenicity of a novel APOA5 variant in familial chylomicronemia syndrome
Objective: This study aimed to evaluate the clinical and functional impact of a novel apolipoprotein A5 (ApoA5) variant by assessing lipoprotein lipase (LPL) activity. Subjects and methods: Demographic and clinical data, including blood lipid levels and body mass index, were retrospectively collected from an endocrinology clinic registry. Ten individuals with familial chylomicronemia syndrome (FCS) carrying a novel APOA5 variant were included. Whole-exome sequencing was performed using the latest generation DNB-SEQ400 platform. LPL activity was measured in post-heparin plasma using a radiometric assay. Statistical analysis: Categorical variables were summarized as frequencies and percentages, and continuous variables as mean ± standard deviation or median (range), as appropriate. Group comparisons were performed using the Mann-Whitney U test or chi-square test. Analyses were conducted using the Statistical Package for the Social Sciences software (v. 25.0). A p-value < 0.05 was considered statistically significant. Results: We report ten cases of FCS with a homozygous missense variant of uncertain significance in APOA5: c.694T>C; p.(Ser232Pro), located in exon 3. In six patients assessed for LPL activity, levels remained consistently below 20% compared to normotriglyceridemic controls. The addition of exogenous serum containing APOA5 restored LPL activity to above 20% in all cases, indicating functional rescue. Conclusion: Measurement of LPL activity demonstrated the functional impact of the APOA5 c.694T>C; p.(Ser232Pro) variant. These findings support reclassification of the variant as likely pathogenic and enable differentiation from multifactorial chylomicronemia syndrome.
- Open Access
- 11 September 2025
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 44, 102245
The Ongoing Utility of lipoprotein lipase activity in diagnosing familial Chylomicronemia Syndrome
- 11 September 2025
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 44, 102245
Open AccessThe Ongoing Utility of lipoprotein lipase activity in diagnosing familial Chylomicronemia Syndrome
- 7 January 2025
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 19 (3) , 701-706
Familial chylomicronemia syndrome caused by 2 genetic variants in the APOA5 gene: Severe hypertriglyceridemia that complicates pregnancy
- 7 January 2025
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 19 (3) , 701-706
Familial chylomicronemia syndrome caused by 2 genetic variants in the APOA5 gene: Severe hypertriglyceridemia that complicates pregnancy
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Lipid and Atherosclerosis
- Vol. 14 (1) , 106-119
Chylomicron Characteristics Are Associated With Microsomal Triglyceride Transfer Protein in an Animal Model of Diet-Induced Dysbiosis
Olano C, et al. J Lipid Atheroscler. 2025 Jan;14(1):106-119. https://doi.org/10.12997/jla.2025.14.1.106
- 1 January 2025
- Published by XMLink in Journal of Lipid and Atherosclerosis
- Vol. 14 (1) , 106-119
Open AccessChylomicron Characteristics Are Associated With Microsomal Triglyceride Transfer Protein in an Animal Model of Diet-Induced Dysbiosis
Olano C, et al. J Lipid Atheroscler. 2025 Jan;14(1):106-119. https://doi.org/10.12997/jla.2025.14.1.106